Stocks
IonQ Stock Analysis: What Investors Should Know in September 2026
As IonQ continues to evolve in the quantum computing sector, investors should consider key factors before making…
Latest by Finbexo Newsroom
CFDs & Trading
Shree Cement Stock Analysis: September 2026 Insights
Shree Cement's stock remains resilient amid strong derivatives trading activity, indicating investor confidence…
Forex
Saudi Arabia Withdraws from mBridge Digital Currency Project
Saudi Arabia has reportedly pulled out of the mBridge digital currency initiative led by China, raising questions…
Stocks
SK Hynix Stock Analysis: September 2026 Earnings Discount
SK Hynix's stock may be undervalued following recent earnings reports, which could present opportunities for…
Stocks
Vanguard ETF Investment Strategy During Market Crash
As concerns grow about a potential stock market crash, investors are considering solid options like Vanguard ETFs…
CFDs & Trading
Bitcoin Derivatives Market Analysis: September 2026
The Bitcoin derivatives market has reached nearly $100 billion, reflecting significant trader interest and…
Forex
Sudan Currency Collapse Impact on Economy September 2026
Ongoing conflict and a collapsing currency are pushing Sudan towards famine, complicating investment in the region…
Stocks
African IPO Creates New Oil Tycoons and Their Memes
A recent IPO in Africa has transformed many investors into oil tycoons, sparking a wave of memes that reflect…
Markets
Weekly Market Update: Stocks Steady, Healthcare Gains, Utilities Decline
Stocks remained flat this week as healthcare sectors saw gains while utilities experienced declines. Key factors…
CFDs & Trading
Axe Compute Inc Derivatives Price Analysis September 2026
Axe Compute Inc's derivatives performance is under scrutiny as AGPU prices fluctuate. This article explores recent…
Markets
US Medicaid Pricing Changes and Their Impact on Forex Markets
The US government plans to implement most-favored-nation pricing for Medicaid drugs nationwide, influencing forex…
Stocks
TG Therapeutics TGTX Stock Analysis: Is It Undervalued This September?
TG Therapeutics' stock has drawn attention for its potential undervaluation based on recent earnings. Here's a…